Share ownership Recordati

REC

IT0003828271

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 08:38:10 2026-01-13 am EST			5-day change	1st Jan Change
48.72 ^EUR	-2.13%		+2.87%	+0.37%

Jan. 12	Recordati Acquires 74,165 Own Ordinary Shares	AN
Jan. 07	STRM.BIO, Inc. announced that it expects to receive funding from Recordati Industria Chimica e Farmaceutica S.p.A., Boehringer Ingelheim, Investment Arm, Delos Advisors Limited and other investors	CI

Share class: Recordati

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	209,058,656	97,865,015 ( 46.81 %)	3,118,842 ( 1.492 %)	46.81 %

Major shareholders: Recordati

Name	Equities	%	Valuation
CVC Advisers Ltd. 46.82 %	97,912,463	46.82 %	5 588 M €
Invesco Asset Management Ltd. 4.115 %	8,605,500	4.115 %	491 M €
Fidelity Management & Research Co. LLC 3.527 %	7,375,844	3.527 %	421 M €
RECORDATI 1.497 %	3,130,654	1.497 %	179 M €
Norges Bank Investment Management 0.9656 %	2,019,319	0.9656 %	115 M €
Fundsmith LLP 0.8645 %	1,807,799	0.8645 %	103 M €
Financière de l'Échiquier SA 0.7585 %	1,586,247	0.7585 %	91 M €
Invesco Advisers, Inc. 0.744 %	1,555,891	0.744 %	89 M €
FMR Investment Management (UK) Ltd. 0.5447 %	1,139,054	0.5447 %	65 M €
The California Public Employees Retirement System 0.2181 %	456,083	0.2181 %	26 M €
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	61.36%
Recordati SpA	1.5%
Unknown	37.14%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom	52.69%
United States	4.69%
Italy	2.27%
Norway	0.98%
France	0.97%
Sweden	0.26%
Ireland	0.21%
Canada	0.19%
Germany	0.12%
Finland	0.09%
Belgium	0.08%
Austria	0.06%
Australia	0.06%
Spain	0.05%
Luxembourg	0.05%
Barbados	0.03%
Denmark	0.02%
Switzerland	0.02%
Portugal	0.01%
Japan	0.01%

Based on 1000 largest holdings

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (35.6%). Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).

Employees

4,539

Sector

Pharmaceuticals

Calendar

Feb. 18 - Q4 2025 Earnings Release (Projected)

More about the company